Tracey Peacock, President, Pharmaceutical & Medical Device Films at kp, says, “We are seeing substantial growth in our barrier product segments in EMEA in response to the increased moisture and oxygen sensitivity of new drugs. We are excited to add significant capacity to our Bern facility to support these trends in our market place.”
This latest investment comes less than 2 years after the addition of significant laminating capacity in EMEA with the expansion of the Pharmaceutical manufacturing center in Montabaur, Germany.
The new capacity will also support the Asian market as it continues to experience doubledigit growth. Ms. Peacock went on to say, “We have been quietly adding to our capabilities in EMEA, and now we must accelerate addressing the growing Asian market place. Asia provides excellent opportunities for kp as regulation continues to increase with many EMEA and US standards being adopted. We are invigorated by the opportunities, and this expansion, supported by local manufacturing and slitting capability in Thailand and China, is just the beginning of some exciting plans we have.” The new capability can be expected to be operational by the end of 2018 with the “simple aim of improving service to our customers wherever they may be in the world,” Peacock concluded.
About Klöckner Pentaplast
The Klöckner Pentaplast Group is a global leader in rigid and flexible packaging, printing and specialty solutions, serving the pharmaceutical, medical device, food, beverage and card markets, amongst others. With a broad portfolio of packaging, films and services, Klöckner Pentaplast plays an integral role in its customers’ value chains, safeguarding product integrity, assuring safety and consumer health, improving sustainability and protecting brand reputation. Founded in 1965, Klöckner Pentaplast has operations in 18 countries and employs over 6,300 people committed to serving customers worldwide from 61 locations, including 32 production sites.
